OPEN END TURBO BULL - JOHNSON & JOHNSON Share Price

Certificat

DE000KE3FGM6

Market Closed - Boerse Frankfurt Warrants 18:30:30 02/05/2024 BST
0.75 EUR +102.70% Intraday chart for OPEN END TURBO BULL - JOHNSON & JOHNSON
Current month+102.70%
1 month-50.33%
Date Price Change Volume
02/05/24 0.75 +102.70% 0
30/04/24 0.37 -13.95% 0
29/04/24 0.43 -4.44% 0
26/04/24 0.45 -13.46% 0
25/04/24 0.52 -21.21% 0

Real-time Boerse Frankfurt Warrants

Last update May 02, 2024 at 06:30 pm

More quotes

Static data

Product typeCertificat Turbo
Buy / SellCALL
Underlying JOHNSON & JOHNSON
IssuerLogo Issuer Citi Citi
WKN KE3FGM
ISINDE000KE3FGM6
Date issued 02/02/2021
Strike 142.3 $
Maturity Unlimited
Parity 10 : 1
Emission price 3.32
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 5.65
Lowest since issue 0.19

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
149.9 USD
Average target price
173.3 USD
Spread / Average Target
+15.57%
Consensus